Now available ZYMFENTRA™

ZYMFENTRA (infliximab-dyyb) injection is a tumor necrosis factor (TNF) blocker indicated in adults for maintenance treatment of:

• moderately to severely active ulcerative colitis following treatment with an infliximab product administered intravenously.
• moderately to severely active Crohn’s disease following treatment with an infliximab product administered intravenously.

Please see full prescribing information here.